导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 9.56% | -0.51% | -0.0488% |
| 688062 | 迈威生物 | 9.33% | 0.72% | 0.0672% |
| 688266 | 泽璟制药 | 9.21% | 0.13% | 0.0120% |
| 688443 | 智翔金泰 | 8.55% | 1.77% | 0.1513% |
| 03692 | 翰森制药 | 7.03% | 2.72% | 0.1912% |
| 688117 | 圣诺生物 | 5.83% | -3.21% | -0.1871% |
| 02162 | 康诺亚-B | 5.34% | 3.20% | 0.1709% |
| 688293 | 奥浦迈 | 5.22% | -3.43% | -0.1790% |
| 01801 | 信达生物 | 3.61% | 2.47% | 0.0892% |
| 688336 | 三生国健 | 3.17% | -0.25% | -0.0079% |
| 重仓股合计:66.85%, 重仓股贡献增长率: 0.259%, 总持股仓位:77.35%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-05-09 | 0.46% | 0.30% |
| 2024-05-08 | 0.20% | -0.47% |
| 2024-05-07 | -0.68% | -0.55% |
| 2024-05-06 | 3.40% | 1.74% |
| 2024-04-30 | -0.35% | -0.34% |
| 2024-04-29 | 0.94% | 1.27% |
| 2024-04-26 | 1.92% | 1.75% |
| 2024-04-25 | 1.16% | 0.77% |
| 基金名称 | 单位净值 | 增长率 |
| 招商沪深300地产等权重指数C | 0.3784 | 4.6936% |
| 港股非银 | 0.9580 | 4.1743% |
| 地产ETF | 0.5961 | 3.9766% |
| 房地产ETF | 0.5392 | 3.9668% |
| 鹏华中证800地产指数(LOF)C | 0.5969 | 3.8251% |
| 鹏华香港银行指数(LOF)C | 1.3943 | 3.7278% |
| 国泰国证房地产行业指数C | 0.6180 | 3.2344% |
| 博时港股通红利精选混合A | 0.9117 | 2.9513% |
| 博时港股通红利精选混合C | 0.8905 | 2.9513% |
| 恒生红利ETF | 0.9788 | 2.8876% |
| 基金名称 | 单位净值 | 增长率 |
| 工银灵动价值混合A | 0.7110 | 3.9343% |
| 工银灵动价值混合C | 0.6991 | 3.9343% |
| 永赢惠添益混合A | 0.6013 | 3.4466% |
| 永赢惠添益混合C | 0.5937 | 3.4466% |
| 永赢惠添盈一年混合 | 0.8881 | 3.4241% |
| 工银核心机遇混合A | 0.6373 | 3.3161% |
| 工银核心机遇混合C | 0.6260 | 3.3161% |
| 博时港股通红利精选混合A | 0.9117 | 2.9513% |
| 博时港股通红利精选混合C | 0.8905 | 2.9513% |
| 华泰柏瑞港股通时代机遇混合A | 0.3962 | 2.8210% |
